Comparing efficacy of supine and prone PCNL in kidney stone patients

A comparative study between Supine and Prone Percutaneous Nephrolithotomy - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065508

Enrollment

200

Registered

2024-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: Supine Percutaneous nephrolithotomy: September, 2022 to August, 2024.(2 years) Control Intervention1: prone percutaneous nephrolithotomy: Patients presenting with renal stone disease in

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with lower calyceal and pelvic renal stone upto size 2cm.

Exclusion criteria

Exclusion criteria: 1.Patients not willing to give consent to participate in the study. 2.Paediatric age group ( 3.Bilateral stone disease. 4.Previous history of PCNL or pyelolithotomy. 5.Uncontrolled cougulopathy. 6.Abnormal renal anatomy.

Design outcomes

Primary

Measure	Time frame
1. Operative time 2.Post op hemoglobin drop 3. Number of blood transfusions 4.Type of complications after procedure (if any) Timepoint: zero day(intra-operative).	—

Secondary

Measure	Time frame
1.Need for Relook PCNL 2.Duration of Hospital Stay 3.Stone Free Rate at 4 weeks Timepoint: At 1 week and 4 weeks.	—

Countries

India

Contacts

Public ContactKhumukcham Somarendra

RIMS,Imphal

drkakurims@gmail.com8974057025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026